These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors. Deppen SA; Liu E; Blume JD; Clanton J; Shi C; Jones-Jackson LB; Lakhani V; Baum RP; Berlin J; Smith GT; Graham M; Sandler MP; Delbeke D; Walker RC J Nucl Med; 2016 May; 57(5):708-14. PubMed ID: 26769865 [TBL] [Abstract][Full Text] [Related]
17. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. Srirajaskanthan R; Kayani I; Quigley AM; Soh J; Caplin ME; Bomanji J J Nucl Med; 2010 Jun; 51(6):875-82. PubMed ID: 20484441 [TBL] [Abstract][Full Text] [Related]
18. Long-Acting Somatostatin Analog Therapy Differentially Alters Ayati N; Lee ST; Zakavi R; Pathmaraj K; Al-Qatawna L; Poon A; Scott AM J Nucl Med; 2018 Feb; 59(2):223-227. PubMed ID: 28729431 [TBL] [Abstract][Full Text] [Related]